Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MRI (magnetic resonance imaging) shines in NICE (UK National Institute for Clinical Excellence) guidance on MS (multiple sclerosis)

This article was originally published in Clinica

Executive Summary

Magnetic resonance imaging (MRI) should be used across the National Health Service whenever needed to confirm the diagnosis of multiple sclerosis (published on November 26 2003). So says the National Institute for Clinical Excellence (NICE), in collaboration with the National Co-ordinating Centre for Chronic Conditions, in guidance on the management of the condition in primary and secondary care.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065394

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel